Medical News

RSS

ABBOTT PRISM Chagas test receives FDA approval

Abbott received Biologic License Application (BLA) approval from the United States Food and Drug Administration (FDA) for the ABBOTT PRISM Chagas test. The test is a fully automated blood screening assay that can detect antibodies to Trypansoma cruzi (T. cruzi), a parasite found only in the Americas and most commonly acquired through contact with the blood-sucking triatomine or "kissing bug."

19 May 2010

PrimeWire PRESTIGE Pressure Guide Wire receives 510(k) clearance, CE Mark approval

Volcano Corporation announced today it received both 510(k) clearance and CE Mark approval for its PrimeWire PRESTIGE Pressure Guide Wire for use with patients who have both single-vessel and multi-vessel disease. This next generation pressure wire is compatible with Volcano's full suite of integrated multi-modality consoles and stand-alone physiology systems as well as various hemodynamic monitoring systems.

19 May 2010

Medical Properties Trust announces new $450 million credit facility

Medical Properties Trust, Inc. announced today that it has entered into a new $450 million credit facility with a syndicate of banks that replaces the Company's existing $220 million credit facility.

19 May 2010

Rosetta Genomics announces publication of study on discovery of microRNAs in solid tumors

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announces the publication of a study entitled, "Discovery of microRNAs and other small RNAs in solid tumors," in the online edition of Nucleic Acid Research.

19 May 2010

Riga to host 3rd Baltic Congress of Osteoporosis

Riga, Latvia will be the venue for the 3rd Baltic Congress of Osteoporosis which will take place on September 3-4, 2010. The congress, to be held in English, is jointly organized by the Latvian Osteoporosis and Bone Metabolism Diseases Association, Lithuanian Osteoporosis Foundation, Lithuanian Association of Metabolic Bone Diseases and the Estonian Osteoporosis Society.

19 May 2010

Experimental evolution used to develop new strains of bacteria for use as probiotic substances

When the forces of evolution took over an experimental strain of bacteria, it derailed an experiment Duke and NC State researchers thought they were conducting, but led to something much more profound instead.

19 May 2010

Plastic corneal prosthesis for patients unable to tolerate donor corneas

For many patients who become blind after an accident or illness, a corneal transplantation could restore the ability to see. Each year, 40,000 people in Europe - in Germany, about 7,000 - await the opportunity to be able to see again, thanks to cornea donors. But donor corneas are not common. Dr. Joachim Storsberg of the Fraunhofer Institute for Applied Polymer Research IAP in Potsdam-Golm developed material and production process for a corneal prosthesis made of plastic.

19 May 2010

BioTeknica, AccuReg help companies achieve realistic FDA compliance goals

Every year, the Food and Drug Administration (FDA), asks hundreds of life science companies to improve their design and manufacturing systems – or risk receiving the ultimate penalty – a Consent Decree; whereby a company must remove its products from the marketplace. It's not easy to navigate FDA regulations because they aren't always "black and white" – in fact; they're often "gray" and open to interpretation depending upon the circumstances.

19 May 2010

Children with new/recent onset epilepsy have slowed expansion of white matter volume

A newly published study reported that children with new/recent onset epilepsy have significantly slowed expansion of white matter volume compared to healthy children over a two year interval. The reduced white matter volume may affect brain connectivity and influence cognition. Results of this study conducted by researchers from the University of Wisconsin School of Medicine and Public Health are now available online and will appear in the July issue of Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.

19 May 2010

HTDS commences subscription to Pink Sheets news and filing service

Hard to Treat Diseases, Inc. announces that the company has commenced to subscribe to Pink Sheets news and filing service after a brief absence.

19 May 2010

Abiomed's Impella revenue for full fiscal year 2010 up 59% to $57.8 million

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2010 revenue of $23.0 million, up 17% compared to revenue of $19.6 million for the same period of fiscal 2009.

19 May 2010

Work stress, economic pressures contribute to weight gain among U.S. labor force: Survey

The combination of work stress and economic pressures appears to be playing a role in the U.S. labor force's weight gain. Overall, 44 percent of workers say they have gained weight in their current jobs, up slightly from 43 percent in 2009, according to a new CareerBuilder survey. Nearly one-third (32 percent) of workers say that stress contributed to their weight gain at work.

19 May 2010

Pantai to implement Stockell Healthcare's InsightCS Patient Access and Revenue Cycle Management solution

Stockell Healthcare Systems, Inc. is pleased to announce that Pantai Holdings Berhad (Pantai) has chosen to implement its InsightCS® Patient Access and Revenue Cycle Management solution across a 10-hospital network located in Malaysia.

19 May 2010

Positive data from Geron's TAT153 small molecule telomerase activator in animal model of IPF

Geron Corporation today announced positive data on its orally available small molecule telomerase activator, TAT153, in an animal model of idiopathic pulmonary fibrosis (IPF). The data show that administration of TAT153 increased telomerase activity in the lung tissue, reduced inflammation, preserved functional lung tissue, slowed disease progression and attenuated loss of pulmonary function.

19 May 2010

Alere announces formation of Collaborative Care Solutions to support physicians, provider groups

With the goal of creating the industry standard for connecting patients and their physician-led care teams, Alere today announced the formation of a new strategic product line, Collaborative Care Solutions. The new product line will be focused on supporting physicians and provider groups wanting to expand their practices via patient-centered medical homes or accountable care organizations -- key care models designed to realize better outcomes and more cost-effective care.

19 May 2010

SBANE recognizes Isis Biopolymer with 2010 Rising Star Award

Isis Biopolymer has been awarded the 2010 Rising Star Award by SBANE (Smaller Business Association of New England). The Rising Star is a coveted annual award that honors innovative products and services offered by early-stage companies in New England.

19 May 2010

USPTO issues Soligenix patent for use of beclomethasone dipropionate in treatment of IBS

Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects approximately 15% of the population in the industrialized world.

19 May 2010

Promosome signs technology license and partnership agreement with Recopharma AB of Stockholm

Promosome LLC, a biotechnology company uniquely dedicated to the development of technologies related to the regulation of protein synthesis through translation initiation, today announced the signing of a technology license and partnership agreement with Recopharma AB of Stockholm, Sweden. Recopharma is a recognized leader in the research and development of therapeutic recombinant mucin-type fusion proteins.

19 May 2010

Oncolytics Biotech initiates Phase I study of REOLYSIN and FOLFIRI in colorectal cancer patients

Oncolytics Biotech Inc. announced today that following submission to the U.S. Food and Drug Administration for review, the Company is initiating a U.S. Phase I study of REOLYSIN(R) in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer.

19 May 2010

BBSRC, EPSRC fund £1.5M for synthetic biology projects under EuroSYNBIO Programme

Four new projects, announced today, will develop biological methods that offer a new approach to antibiotic production, power generation for extremely small mechanical components, new classes of medicines and innovative techniques to study cell biology.

19 May 2010

Medical News

ABBOTT PRISM Chagas test receives FDA approval

PrimeWire PRESTIGE Pressure Guide Wire receives 510(k) clearance, CE Mark approval

Medical Properties Trust announces new $450 million credit facility

Rosetta Genomics announces publication of study on discovery of microRNAs in solid tumors

Riga to host 3rd Baltic Congress of Osteoporosis

Experimental evolution used to develop new strains of bacteria for use as probiotic substances

Plastic corneal prosthesis for patients unable to tolerate donor corneas

BioTeknica, AccuReg help companies achieve realistic FDA compliance goals

Children with new/recent onset epilepsy have slowed expansion of white matter volume

HTDS commences subscription to Pink Sheets news and filing service

Abiomed's Impella revenue for full fiscal year 2010 up 59% to $57.8 million

Work stress, economic pressures contribute to weight gain among U.S. labor force: Survey

Pantai to implement Stockell Healthcare's InsightCS Patient Access and Revenue Cycle Management solution

Positive data from Geron's TAT153 small molecule telomerase activator in animal model of IPF

Alere announces formation of Collaborative Care Solutions to support physicians, provider groups

SBANE recognizes Isis Biopolymer with 2010 Rising Star Award

USPTO issues Soligenix patent for use of beclomethasone dipropionate in treatment of IBS

Promosome signs technology license and partnership agreement with Recopharma AB of Stockholm

Oncolytics Biotech initiates Phase I study of REOLYSIN and FOLFIRI in colorectal cancer patients

BBSRC, EPSRC fund £1.5M for synthetic biology projects under EuroSYNBIO Programme

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News